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Abstract
The outer membrane protein B (OmpB) of the typhus group rickettsiae is an immunodominant antigen and has been shown to provide
protection against typhus in animal models. Consequently, OmpB is currently being considered as a potential rickettsiae vaccine candidate to
be used in humans. The OmpB from virulent strains are heavily methylated while the attenuated strains are hypomethylated. Western blot
analysis of partially digested OmpB revealed that one of the reactive fragments was located at the N-terminus (fragment A, aa 33–272).
Recently, we have over expressed, purified, and chemically methylated the recombinant fragment A from Rickettsia prowazekii (Ap). The
methylated Ap was thoroughly characterized by LC/MS/MS on the ProteomeX workstation. The protein sequence of Ap with and without
methylation was 87.7% and 100% identified, respectively. This high sequence coverage enabled us to determine the sites and extent of
methylation on the lysine residues in Ap. All the lysine residues except the C-terminus lysine were either mono-, di- or tri-methylated. In
addition, carbamylation on the N-terminus glycine was identified using a combination of denovo sequencing (DeNovoX) and the pattern
recognition (SALSA) program with accurate mass measurement. We demonstrated that the use of peptide identification (SEQUEST) in
combination with SALSA and denovo sequencing provided a useful means to characterize the sequence and posttranslational modifications
of given proteins.
D 2004 Elsevier B.V. All rights reserved.
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1. Introduction
Rickettsia prowazekii, the etiologic agent of epidemic
typhus, has the potential to be selected as a biological
weapon by terrorists and rogue countries because of its
stability in dried louse feces and in its infection by
inhalation of aerosol [1]. In 1975, the World Health
Organization estimated 104,000 casualties, with 19,000
dead and 85,000 incapacitated, following a hypothetical
air deployment of 50 kg of typhus agent before the
technology of generating drug resistant strains had been
documented [2]. The death toll with drug resistant strains
could be much higher. R. prowazekii is highly resistant to all
but two classes of common antibiotics, namely the
tetracyclines and chloramphenicol [3,4]. Recently, R.
prowazekii was made resistant to rifampin and erythromycin
by electroporation of a plasmid containing the resistant gene
[5,6]. The creation of tetracycline or chloramphenicol
resistant strains, which will be much easier now with the
availability of the whole genome sequence of R. prowazekii,
would create one of the most dangerous threats available for
the use of bioterrorists [7].
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R. prowazekii has a monomolecular layer of protein
arranged in a periodic tetragonal array on its surface [8].
This crystalline layer, representing 10 to 15% of the total
protein mass of the rickettsia, was identified as the
immunodominant species-specific surface protein antigen
(i.e., outer membrane protein B, OmpB). The OmpB was
isolated, purified, and biochemically characterized [9–12].
The earliest and dominant immunological anti-protein
responses were directed against Omp B in mice, guinea
pigs, rabbits, and humans following infection with R.
prowazekii [13–17]. It has been shown that purified native
typhus OmpB induced strong humoral and cell-mediated
immune responses. Protective immunity was elicited by
typhus OmpB in guinea pig and mouse protection models
[13,15,17]. Outer membrane proteins have also been shown
to be the major virulence determinants in other Gram-
negative organisms, such as Aeromonas salmonicida and
Campylobacter fetus [18,19], suggesting OmpB may be a
good vaccine candidate. Western blot analysis of partially
digested OmpB using patient sera revealed that all the
reactive fragments were larger than 20 kDa [20]. Among
these reactive fragments, one of them was located at the N-
terminus (fragment A).
Different reactive fragments, including fragment A, as
well as full-length OmpB are known to have posttransla-
tional modifications (i.e., methylation). Previously, we
demonstrated that lysine residues were heavily methylated
in OmpB from virulent strains but hypo-methylated in those
from attenuated strains [9,21] by amino acid composition
analysis. In an attempt to generate recombinant reagents that
mimic rickettsia derived antigens, we cloned and expressed
a recombinant fragment A consisting of amino acid residues
33–272 of the OmpB from R. prowazekii (Ap). The E. coli
expressed Ap was purified, refolded, and then chemically
methylated under a vacuum with the volatile reagent CH3I.
Previous approaches using Edman degradation and amino
acid composition analysis could not fully characterize the
entire protein fragment, especially the sites and level of
multiple methylation such as mono-, di- and tri-methylation.
In this report, we demonstrated the use of a LC-MS, denovo
sequencing and motif pattern recognition software to
identify the entire sequence and its posttranslational
modification of lysine with methylation. The same approach
has also been used for the subsequent characterization of
methylation sites in the naturally occurring OmpB.
2. Materials and methods
2.1. Production of recombinant protein Ap
Specific primers for protein Ap (forward: 5V-
TCTGGTGTACATATGGGTGCTG(T/C)TATGCAATA-
TAATAG-3V, reverse: 5V-ACTGACGGATCCTTATTAAC-
CAGTACCGTCT(C/A)TTCCATTAAAAT-3V) were
designed and synthesized by Life Technology (Gaithers-
burg, MD, USA). The genomic DNA of R. prowazekii was
used as a template in polymerase chain reaction (PCR) to
generate the desired fragment Ap. The amplified fragment
was ligated into the plasmid pET24a (Novagen, Madison,
WI, USA) and was transfected into E. coli BL21 (Novagen).
Cells were grown in 2YT medium followed by induction of
protein expression with 1 mM IPTG (isopropyl B-d
thiogalactopyranoside; Sigma-Aldrich, St. Louis, MO,
USA) for 3 h. Following centrifugation at 4000 rpm for
20 min, the cell pellet was resuspended in buffer A (20 mM
Tris–HCl, pH 8.0, Sigma-Aldrich), containing 5 mM EDTA
and 1 mM phenylmethylsulfonyl fluoride (Sigma-Aldrich),
and disrupted by sonication. The overexpressed recombi-
nant Ap in inclusion body was pelleted and washed
sequentially with 2 M urea (Acros, Pittsburgh, PA, USA)
and 2% deoxy cholate (Sigma-Aldrich) in Buffer A. The
washed inclusion bodies dissolved in 8 M urea were purified
by DEAE anion-exchange chromatography with a linear
NaCl (Sigma-Aldrich) gradient of 0.70–0.86 M in 8 M urea,
20 mM Tris–HCl, pH 8.0. The peak fractions containing the
majority of protein Ap were near homogeneity as deter-
mined by SDS-PAGE (Invitrogen, Carlsbad, CA, USA).
The N-terminal sequence of Ap was confirmed by Procise
491 protein sequencer (Applied Biosystems, Foster City,
CA, USA).
2.2. Refolding of purified recombinant Ap
The purified Ap in 8 M urea was refolded by sequential
dialysis in decreasing concentrations of urea as described by
Ching et al. [22]. Approximately 0.5 mg/mL of the purified
polypeptides in 8 M urea in Tris–HCl buffer was transferred
into a dialysis bag (24 mm, MWCO 12,000 Da) and
dialyzed sequentially against 6, 4, 2, and 0 M urea in the
buffer for 30 min twice at each concentration of urea with
gentle stirring. All dialysis procedures except the last step
without urea were done at room temperature; usually three
dialysis bags with 10 mL each in a 500-mL beaker or 20 mL
each in a 1000-mL beaker were dialyzed against buffer at a
ratio of 1:15. The dialysis was continued overnight without
urea in large excess of buffer A at 4 8C to remove traces of
urea.
2.3. Chemical methylation of recombinant Ap
Refolded Ap was lyophilized in 20 mM Tris–HCl, pH
8.0. The lyophilized Ap was used for chemical methylation
with CH3I (Sigma-Aldrich) under vacuum at 37 8C for 18 h
as described by Taralp and Kaplan [23].
2.4. Determination of multiple methylation at lysine residues
by liquid chromatography-mass spectrometry (LC/MS,
ProteomeX)
One milligram each of refolded Ap with or without
methylation was denatured in 1 mL of 6 M guanidine
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HCl (Sigma-Aldrich), reduced by 10-AL 1 M dithiothreo-
tol (Sigma-Aldrich), alkylated by 25-AL 1 M iodoaceta-
mide (Sigma-Aldrich) at room temperature in the dark.
The sample was washed three times in a centricon
(10,000 MW cutoff, Millipore, Billerica, MA, USA) with
100 mM ammonia bicarbonate (Sigma-Aldrich). The
solution in the final wash was collected and adjusted to
a total volume of 1 mL with 100 mM ammonia
bicarbonate. The 1 mg/mL of protein solution was
digested with 20 Ag trypsin (Promega, Madison, WI,
USA) overnight at 37 8C. Another 20-Ag trypsin was
added for an additional 6-h digestion at 37 8C. The
digested protein (1 Ag) was loaded onto a capillary
reversed phased column (75 Am ID10 cm, Biobasic-
C18, ThermoHypersil, Bellefonte, PA, USA) and eluted
with a linear gradient of 5–65% acetonitrile (VWR,
Bridgeport, NJ, USA) in 60 min. The eluted peptides
were introduced into an electrospray ionization, ion trap
mass spectrometer (DecaXP Plus or LTQ FT, Thermo
Electron, Waltham, MA, USA) for peptide sequence
analysis and accurate mass measurement. The SEQUEST
search results were initially assessed by examination of
the Xcorr (cross correlation) and DCn (delta normalized
correlation) scores. The Xcorr function measured the
similarity of mass-to-charge ratios (m/z) for the fragment
ions between the predicted value from published amino
acid sequences and the observed value from the MS/MS
spectrum. The DCn score was obtained by normalizing
the Xcorr values to 1.0 and calculating the difference
between the first- and second-ranked amino acid sequen-
ces [24]. Thus, the DCn score discriminated high quality
spectra from noisy spectra even when both spectra may
have matched a theoretical spectrum. The Sp is the
preliminary score assigned after initial comparison
between the theoretical generated spectra and the exper-
imental spectra. As a general rule, an Xcorr value of
greater than 2.5 for triply, 2.0 for doubly and 1.5 for
singly charged ions and a DCn greater than 0.1 were
accepted as a positive identification [25,26]. Manual
inspections of key spectra were performed to confirm
the SEQUEST result. Bioworks 3.1 was used to construct
a unified ranking score based on the three matching
factors (Sp, Xcorr, and DCn) [27]. Two additional
programs DeNovoX and SALSA for pattern recognition
as part of the BioWorks 3.1 package (Thermo Electron,
Waltham, MA, USA) were applied for further analysis of
the otherwise unidentified spectra and posttranslational
modifications.
3. Results
3.1. Purification of recombinant Ap
Production of recombinant Ap was carried out as
described in Materials and methods. The recombinant
Ap, purified by DEAE anion exchange chromatography,
was analyzed by SDS-PAGE (Fig. 1). A single band at
approximately 26 kDa stained by Coomassie blue is shown
in the insert of Fig. 1.
3.2. Characterization of recombinant Ap before and after
methylation
The Ap in the SDS-PAGE gel was transferred onto a
PVDF membrane for the subsequent Edman N-terminal
amino acid sequence analysis. The results were consistent
with the expected sequence (Fig. 4, underlined sequence).
The infrared absorption spectra for Ap before and after
methylation exhibited significant differences, suggesting
that the secondary structure of Ap was changed after
methylation (data not shown). Methylated Ap showed
higher apparent molecular weight than the non-methylated
control as indicated by their electrophoretic mobility in
SDS-PAGE (data not shown).
3.3. LC-MS analysis of multiple methylation on lysine
residues
The tryptic digests of the methylated and non-methy-
lated Ap were each loaded onto separate capillary C-18 LC
columns for LC-MS analysis (see Materials and methods
for details). The profiles of ion intensity vs. elution time for
methylated and non-methylated Ap are shown in Fig. 2,
panels A and B, respectively. The eluted peptides from the
reversed phase column were introduced into the ion trap by
electrospray ionization. The first full MS scan yielded
precursor ions and the top three most abundant precursor
Fig. 1. Chromatogram of recombinant Ap purification. The recombinant
Ap was purified by DEAE anion exchange chromatography with
Agilent 1100 HPLC. The elution chromatogram is shown as a plot of
time (minutes, X-axis) vs. absorbance (OD at 276 nm, Y-axis). The
shallow linear gradient of NaCl from 0.7 to 0.86 M in 30 min was
also plotted. The peak fraction (indicated by arrow) eluted from the
DEAE anion exchange column was analyzed by SDS-PAGE as shown
in the insert.
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ions were selected for collisional induced fragmentation (set
at 35%) to yield sequence information (MS/MS scan).
The aforementioned LC-MS analysis relied on a pro-
grammed MS/MS fragmentation performed on selected
ions. The resulting MS/MS spectra were then matched
with predicted spectra from protein databases or the
known protein sequence database (e.g., Ap protein
sequence). Typically, the ions for MS/MS analysis were
selected based on signal intensity. The SEQUEST soft-
ware automatically assigned MS/MS spectra to peptide
sequences or modified peptide sequences (e.g., peptide
sequence modified by methylation on lysine residue),
calculated a probability for this assignment, and then
matched peptides to possible protein identifications [28].
Examples of the methylated (Panel a) and non-methylated
(Panel b) peptide assignments are shown in Fig. 3. The
peptide sequences were usually fragmented at their amide
bond linkage, generating byQ ions and bbQ ions (modified
Roepstorff and Fohlmann notation). Thus, a series of
either byQ or bbQ ion matches usually gave a high Xcorr
score for the assignment (see Materials and methods for
details).
There were two important factors for obtaining the high
sequence coverage. First, the enzymatic digestion con-
ditions used should be optimized for complete cleavage.
We used a double dose of trypsin in sequential intervals
as described in Materials and methods. Often, the
hydrophobic domain or the modification at the tryptic
cleavage sites rendered an incomplete digestion. However,
once the proteins were partially unfolded, the second dose
of trypsin was able to further digest the fragmented proteins
to yield more complete cleavages. Some nonspecific
cleavage may have occurred because of the second dose
of trypsin, increasing the complexity added onto the
digested peptides. The second important factor was a
software package to recognize every possible cleavage in
order to compare the experimental MS/MS spectra with the
theoretical MS/MS spectra. After intensive search and
comparison using SEQUEST, we found that 100% of the
sequence of the non-methylated Ap was identified whereas
87.7% of the complete sequence of the methylated Ap (Fig.
4) was identified. In these identified sequences, we found
peptides containing mono-, di- and tri-methylated lysines
(Fig. 4). The spectra of peptides containing modified lysines
were carefully examined manually to assure the assignments
were correct. Among the six lysines in the methylated Ap,
four of them were mono-, di-, and tri-methylated, one was
mono-, and di-methylated and the C-terminus lysine was
not observed.
Visual inspection of a MS/MS spectrum from a peptide
that was not identified by SEQUEST search using a
database containing Ap sequence showed a peptide-like
fragmentation character. The presence of unanticipated
posttranslational modifications (PTMs) was suspected.
Using de novo sequence software (DenovoX), we identi-
fied the partial sequence VMQYNR, which was used to
research the protein database. This sequence matched a
partial sequence of the OmpB from R. typhi. As shown in
Fig. 5, there was an additional 43 Da unaccounted for even
if an extra GA was added to the sequence according to the
sequence of full-length OmpB from R. typhi. The differ-
ence of 43 Da may be accounted for by a carbamylation
because of the presence of urea in our protein purification
process.
The results of sequence motif search (SALSA) con-
firmed that the sequence of GAVMQYNR was modified
Fig. 2. LC/MS/MS elution profile of methylated (Top) and non-methylated (Bottom) Fragment Ap. The base peak ion abundance (Y-axis) was plotted against
time (minutes, X-axis). The analysis details were described in the Materials and methods.
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(Fig. 6). SALSA searched all MS/MS spectra for those that
contain the specified motif and found two doubly charged
precursor ions differed by 21.56 Da, suggesting that the
difference was due to carbamylation on the N-terminal
glycine residue. These results were further evaluated by
analyzing the methylated Ap with an FTMS and were
Fig. 3. Example of the MS/MS spectra of the peptide from a doubly charged, methylated peptide from Ap is shown in Panel a. The tri-methylated lysine was
labeled with @ and was confirmed by the signal at 1975.8 (m/z). The singlet charged ion from non-methylated Ap is shown in Panel b; only partial sequence of
the identified peptide was shown. The matched byQ and bbQ ions are displayed.
Fig. 4. Tryptic peptides eluted from the LC-MS were identified by BioWorks 3.1. The sequence of fragment Ap is shown with the peptides identified in both
methylated (87.7%) and non-methylated (100%) Ap shown in upper case letters. The peptides not identified in non-methylated Ap are in lowercase letters. The
lysines with different extents of methylation are shown as k: un, K: mono-, di- and tri-methylated lysine, K: mono- and di-methylated lysine.
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confirmed that carbamylation was associated with the N-
terminal glycine (data not shown).
4. Discussion
We have previously demonstrated by amino acid compo-
sition analysis that OmpB from virulent strains was hyper-
methylated and that from attenuated strains was
hypomethylated [21]. In this report, we attempted to generate
recombinant antigens to replace the whole cell antigens
currently used in laboratory diagnosis for epidemic typhus.
To characterize the chemically methylated recombinant
antigen, we not only identified the sites of methylation on
recombinant Ap, but also the extent of methylation on each
available lysine in recombinant Ap. In addition, this is the
first time that a LC-MS technique was used to directly
pinpoint the sites of methylation on a recombinant fragment
of this outer membrane protein.
A chemically methylated recombinant fragment A from R.
typhi (At) showed higher reactivity than non-methylated At
with patient sera in an enzyme linked immunoabsorbant
assay (Ching et al., unpublished results). This suggested the
potential use of chemically modified fragments instead of
native fragments as antigens in diagnostic test kits or as
vaccine components. However, chemical methylation of
recombinant proteins may not have the same selectivity as
the enzymatic methylation derived in vivo. Nevertheless, the
chemical methylation provided a useful platform to study the
effect of methylation on the sero-reactivity of fragment At,
and the methylated fragment At appeared to maintain the
epitopes required to react with antibodies in patients’ sera.
Stewart et al. have established a condition where chemical
methylation occurred exclusively on lysine residues using
small peptides as their model compounds [29]. They further
confirmed an exclusive tri-methylation on lysine residues
occurred under the experimental condition. We followed
similar procedures but the reaction temperature was at 37 8C
instead of 72 8C in order to maintain the folded structure of
Ap since reaction at 72 8C may denature our expressed
protein. In contrast to an exclusive tri-methylation reaction
observed at 72 8C, lower temperature at 37 8C may have
contributed to the multiple methylation patterns, i.e., addition
of mono-, di- or tri-methyl groups on a single lysine (Kaplan,
personal communication). However, with the preliminary
data on the analysis of lysine methylation of rickettsial
derived OmpB, we also found similar complexity of
methylation patterns on these lysine residues (data not
shown), indicating that the methylation reaction in vivo led
to the addition of mono-, di- or tri-methyl groups on a single
lysine. These observations suggested that our chemical
methylation in vitro at 37 8C mimics the in vivo methylation
more closely than the in vitro reaction at 72 8C.
Due to the decreased enzymatic activity of trypsin at
trimethylated lysines [30], tryptic digestion of methylated Ap
may not have been completed. Some peptides appeared to be
quite long because cleavage occurred only at arginine
residues (and not lysine residues). Some peptides were not
cleaved at either lysine or arginine but at nonspecific sites.
The nonspecific cleavage was probably a result of the two
sequential trypsin digestions used or minor protease con-
taminants (i.e., chymotrypsin activity) in the trypsin source.
When using SEQUEST to consider all possible cleavages,
we found additional peptides that were not identified initially
Fig. 5. De novo sequencing by DeNovoX of an unidentified mass spectrum. De novo sequence of a mass spectrum not identified by SEQUEST, indicating an
N-terminal modified glycine residue.
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when using trypsin specificity as the search parameter. This
strategy resulted in 100% and 87.7% sequence coverage for
non-methylated and methylated Ap, respectively.
The protein sequencing data using Edman degradation
revealed a mutation near the N-terminus where an alanine
(GAAMQYNR, R. prowazekii) was replaced with a valine
(GAVMQYNR, R. typhi). It is important to point out that the
N-terminal amino acid was not methionine as determined by
both the N-terminal protein sequencer and mass spectrom-
eter analysis despite the fact that the expression plasmid was
designed with methionine as the N-terminal amino acid. The
removal of methionine was probably related to the in vivo
protein processing in bacterial expression system. The fact
that an alanine was replaced with a valine was due to the
forward primer used for polymerase chain reaction (PCR)
amplification, which was designed for both organisms.
With the help of computer software (DenovoX), we were
able to perform de novo sequence using the MS/MS spectra
and determined the sequence of an unknown peptide. This
was demonstrated in our search for the N-terminal amino acid
residues. Our original search against the database of OmpB
from R. prowazekii did not identify this N-terminal residue;
however, de novo sequencing identified the sequence
VMQYNR. This VMQYNR was used for subsequent data-
base searches to identify it as the partial N-terminal sequence
of OmpB of R. typhi (GAVMQYNR). This verified the
advantage of de novo sequencing and further confirmed the
sequence identified by protein sequencing.
A pattern recognition software (SALSA) was used to look
for a specific motif and specific modifications on the motif
[31]. By doing this, we identified a motif (GAVMQYNR)
that showed a mass difference of 43.12 Da of two doubly
charged precursor ions in the full MS spectra, indicating the
possibility of a modification at the N-terminal glycine. Since
the protein was purified in the presence of urea, it was
possible that N-terminal glycine was carbamylated. A small
aliquot of sample was thus analyzed by a Fourier transform
mass spectrometer (LTQ FT mass spectrometer) with
accurate mass measurement and the results confirmed that
the N-terminal glycine was mainly carbamylated (Supple-
mental Fig. 1). The FTMS data clearly demonstrated the
observed isotope distribution of MS spectrum of the 491.62
precursor ion was identical to the theoretical MS spectrum
of the carbamylated N-terminal glycine peptide, confirming
the N-terminal glycine was carbamylated.
In the above approach using the combination of de novo
sequencing (interprets peptide sequences from their MS/MS
spectra) and SALSA (detects specific features in MS/MS
spectra and scores the spectra based on how many of the
features are displayed and their intensities in the spectrum)
[31], it was possible to identify peptide sequences that were
not identified by SEQUEST. Consequently, we identified a
peptide sequence (GAVMQYNR) with and without a
carbamylation. Although the carbamylated and non-carba-
mylated peptides appeared to have similar MS/MS spectra,
their precursor ion masses were different.
In conclusion, we have demonstrated the sites and extent
of methylation in a chemically methylated recombinant Ap.
This chemically methylated protein was used as a model
system to study its reactivity toward patient serum for the
development of diagnostic tools. We are currently analyzing
the variation of methylation in outer membrane proteins
from a variety of rickettsiae to better understand the
influence of location and extent of methylation of the outer
membrane protein on the virulence of rickettsiae.
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